博瑞医药大跌5% 一季报业绩下滑

智选洞察2025-04-18

04月18日，博瑞医药（688166）股价大幅下跌，截至09点58分，博瑞医药下跌5.46%，报37.02元/股，成交1.03亿元，换手率0.64%，振幅5.39%。消息解读2025年4月18日，博瑞医药(688166.SH)发布2025年一季报。公司营业总收入为2.49亿元，较去年同报告期营业总收入减少9117.33万元，同比较去年同期下降26.81%。归母净利润为1295.98万元，较去年同...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2528070736?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-18 09:58","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2528070736","market":"sh","top_or_hot":-1,"title":"博瑞医药大跌5% 一季报业绩下滑","media":"智选洞察","content":"<div>\n<p>04月18日，博瑞医药（688166）股价大幅下跌，截至09点58分，博瑞医药下跌5.46%，报37.02元/股，成交1.03亿元，换手率0.64%，振幅5.39%。消息解读2025年4月18日，博瑞医药(688166.SH)发布2025年一季报。公司营业总收入为2.49亿元，较去年同报告期营业总收入减少9117.33万元，同比较去年同期下降26.81%。归母净利润为1295.98万元，较去年同...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095904a45d4781&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>博瑞医药大跌5% 一季报业绩下滑</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n博瑞医药大跌5% 一季报业绩下滑\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-18 09:58 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095904a45d4781&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>04月18日，博瑞医药（688166）股价大幅下跌，截至09点58分，博瑞医药下跌5.46%，报37.02元/股，成交1.03亿元，换手率0.64%，振幅5.39%。消息解读2025年4月18日，博瑞医药(688166.SH)发布2025年一季报。公司营业总收入为2.49亿元，较去年同报告期营业总收入减少9117.33万元，同比较去年同期下降26.81%。归母净利润为1295.98万元，较去年同...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095904a45d4781&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688166","symbol_name":"博瑞医药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095904a45d4781&s=b","article_id":"2528070736","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095904a45d4781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2528070736","pubTimestamp":1744941510,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"04月18日，博瑞医药股价大幅下跌，截至09点58分，博瑞医药下跌5.46%，报37.02元/股，成交1.03亿元，换手率0.64%，振幅5.39%。消息解读2025年4月18日，博瑞医药发布2025年一季报。资金动向截止发稿，博瑞医药获得主力净流出741万元，其中超大单流出179万元，大单流出560万元。最新财报显示，今年一季报，博瑞医药实现营业收入2.49亿元，同比减少26.81%，净利润为1,295.98万元，同比减少79.77%，基本每股收益为0.03元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688166":"博瑞医药","BK0239":"医药制造"},"translate_title":"Borui Pharmaceuticals fell 5%, first-quarter results fell","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688166":1},"content_text":"04月18日，博瑞医药（688166）股价大幅下跌，截至09点58分，博瑞医药下跌5.46%，报37.02元/股，成交1.03亿元，换手率0.64%，振幅5.39%。消息解读2025年4月18日，博瑞医药(688166.SH)发布2025年一季报。公司营业总收入为2.49亿元，较去年同报告期营业总收入减少9117.33万元，同比较去年同期下降26.81%。归母净利润为1295.98万元，较去年同报告期归母净利润减少5111.01万元，同比较去年同期下降79.77%。经营活动现金净流入为1.07亿元，较去年同报告期经营活动现金净流入减少4146.88万元，同比较去年同期下降27.93%。公司最新毛利率为43.95%，较上季度毛利率减少13.56个百分点，较去年同期毛利率减少13.22个百分点。最新ROE为0.52%，较去年同期ROE减少2.12个百分点。公司摊薄每股收益为0.03元，较去年同报告期摊薄每股收益减少0.12元，同比较去年同期下降80.00%。此外，数据统计显示，近半年内3家券商给予增持建议，4家券商给予买入建议。资金动向截止发稿，博瑞医药获得主力净流出741万元，其中超大单流出179万元，大单流出560万元。数据显示，该股今日净流入较近5日净流入均值减少920万元。融资融券方面，博瑞医药04月16日获得融资净买入970万元，当日该股融资余额为13.74亿元，当较前一日增加0.71%，实现3连增；该股融券余额为216万元，融券余量为5.84万股，比上日增加28.26%。主营业务及业绩博瑞医药公司主营业务为研发和生产高端仿制药和原创性新药。最新财报显示，今年一季报，博瑞医药实现营业收入2.49亿元，同比减少26.81%，净利润为1,295.98万元，同比减少79.77%，基本每股收益为0.03元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528070736","isCrawlerRequest":true}